Penis carcinoma in situ

disease
On this page

Also known as Bowen disease of the penisBowen's disease of penisBowen's disease of the peniscarcinoma in situ of peniscarcinoma in situ of the peniserythroplasia of Queyratgrade III penile intraepithelial neoplasiagrade III squamous intraepithelial lesion of penisgrade III squamous intraepithelial lesion of the penispenile carcinoma in situpenile carcinoma in situ aJCC v7penis in situ carcinomaQueyrat erythroplasiaQueyrat's erythroplasiastage 0 penile carcinoma in situstage 0 penis carcinoma

Summary

Penis carcinoma in situ (MONDO:0004671) is a cancer. A subtype of squamous carcinoma in situ — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namepenis carcinoma in situ
Mondo IDMONDO:0004671
DOIDDOID:8872
ICD-10-CMD07.4
NCITC27790
SNOMED CT398831006
UMLSC0154089
MedGen102309
GARD0024082
Anatomy (UBERON)UBERON:0000989
Is cancer (heuristic)yes

Also known as: Bowen disease of the penis · Bowen’s disease of penis · Bowen’s disease of the penis · carcinoma in situ of penis · carcinoma in situ of the penis · erythroplasia of Queyrat · grade III penile intraepithelial neoplasia · grade III squamous intraepithelial lesion of penis · grade III squamous intraepithelial lesion of the penis · penile carcinoma in situ · penile carcinoma in situ aJCC v7 · penis in situ carcinoma · Queyrat erythroplasia · Queyrat’s erythroplasia · stage 0 penile carcinoma in situ · stage 0 penis carcinoma

Disease family

This is a subtype of squamous carcinoma in situ. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmcancercarcinomain situ carcinomasquamous carcinoma in situpenis carcinoma in situ

Related subtypes (2): trachea carcinoma in situ, skin squamous cell carcinoma in situ

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.